TABLE 3.

Frequency with which various sexual assault care components are provided by dSAFEs (n = 51) and ndSAFEs (n = 50) at hospitals that have these services.

Services	dSAFE (n)	dSAFE (%)	95% CI	ndSAFE (n)	ndSAFE (%)	95% CI
Forensic evidence collection	50	98.0	94.2%–100%	30	60	46.4%–73.6%
Genital exam for forensic purposes	46	90.2	82.0%–98.4%	30	60	46.4%–73.6%
Follow‐up resource provision	46	90.2	82.0%–98.4%	41	82	71.4%–92.6%
Genital exam for clinical purposes	24	47.1	33.4%–60.8%	18	36	22.7%–49.3%
Testing and prophylaxes for STIs
HIV	16	31.4	18.6%–44.1%	23	46	32.2%–59.8%
Non‐HIV	19	37.3	24.0%–50.5%	23	46	32.2%–59.8%
Testing and prophylaxis for pregnancy	18	35.3	22.2%–48.4%	22	44	30.2%–57.8%
Clinical toxicology testing	14	27.5	15.2%–39.7%	18	36	22.7%–49.3%
Forensic toxicology testing	19	37.3	24.0%–50.5%	19	38	24.5%–51.5%

Abbreviations: CI, confidence interval; dSAFE, dedicated sexual assault forensic examiner; HIV, human immunodeficiency virus; ndSAFE, non‐dedicated sexual assault forensic examiner; STIs, sexually transmitted infections.